During the past decade, NYU Langone Long Island Clinical Research Associates conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NYU Langone Long Island Clinical Research Associates" #1 sponsor was "Pfizer" with 5 trials, followed by "Shire" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Long Island Clinical Research Associates" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NYU Langone Long Island Clinical Research Associates" are "Crohn's Disease" (9 trials), "Ulcerative Colitis" (7 trials), "Crohn Disease" (3 trials), "Colitis, Ulcerative" (1 trials) and "Ulcerative Colitis and Crohn's Disease" (1 trials). Many other conditions were trialed in "NYU Langone Long Island Clinical Research Associates" in a lesser frequency.

Most popular intervention types in "NYU Langone Long Island Clinical Research Associates" are "Drug" (18 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Filgotinib" (4 trials), "CP-690,550" (3 trials), "Ontamalimab" (3 trials) and "GED-0301" (2 trials). Other intervention names were less common.

The vast majority of trials in "NYU Langone Long Island Clinical Research Associates" are 20 trials for "All" genders.

Currently, there are NaN active trials in "NYU Langone Long Island Clinical Research Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in NYU Langone Long Island Clinical Research Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in NYU Langone Long Island Clinical Research Associates, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".